missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ GLP1R Polyclonal Antibody
Goat Polyclonal Antibody
Brand: Invitrogen™ PA5142936
This item is not returnable.
View return policy
Description
Additional Information: The immunizing peptide represents part of an extracellular region. This antibody is tested in Peptide ELISA: antibody detection limit dilution 1:128,000.
Glucagon-like peptide-1(9-36)amide and GLP-1(9-37) are the forms of GLP-1 that result from the rapid degradation of the active forms of the peptide (GLP-1(7-36)amide and GLP-1(7-37)) by the enzyme dipeptidyl peptidase-IV (DPP-IV, also known as CD26 or adenosine deaminase binding protein). GLP-1 is a peptide hormone of the glucagon family, produced by the L cells of the intestinal mucosa from the same prohormone as glucagon. The active forms are potent stimulators of glucose-dependent insulin secretion. The sequence of GLP-1 is fully conserved in all mammalian species examined so far.
Specifications
| GLP1R | |
| Polyclonal | |
| Unconjugated | |
| Glp1r | |
| Glip; GLP-1; GLP1 receptor; GLP-1 receptor; GLP1R; GLP-1R; GLP-1-R; GLP1Rc; GLP-I receptor; Glpr; glucagon like peptide 1 receptor; glucagon-like peptide 1 receptor; glucagon-like peptide-1 receptor; LOW QUALITY PROTEIN: glucagon-like peptide 1 receptor; glucagon-like peptide 1 receptor; pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1; RATGL1RCP; seven transmembrane helix receptor | |
| Goat | |
| Ammonium sulfate precipitation | |
| RUO | |
| 14652, 2740 | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Liquid |
| Immunohistochemistry (Paraffin), Western Blot | |
| 0.5 mg/mL | |
| TBS with 0.5% BSA and 0.02% sodium azide; pH 7.3 | |
| O35659, P43220 | |
| Glp1r | |
| Peptide with sequence C-SKRGERNFPEEQ (aa 129-140). | |
| 100 μg | |
| Primary | |
| Human, Mouse | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction